96 related articles for article (PubMed ID: 22507985)
1. Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.
Uchida M; Harada T; Enkhtuya J; Kusumoto A; Kobayashi Y; Chiba S; Shyaka A; Kawamoto K
Biochem Biophys Res Commun; 2012 May; 421(2):323-8. PubMed ID: 22507985
[TBL] [Abstract][Full Text] [Related]
2. Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency.
Oh Y; Kim JA; Kim CH; Choi SK; Pan JG
BMC Vet Res; 2020 Jul; 16(1):259. PubMed ID: 32723323
[TBL] [Abstract][Full Text] [Related]
3. Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.
Malik A; Gupta M; Mani R; Gogoi H; Bhatnagar R
Front Immunol; 2018; 9():562. PubMed ID: 29616046
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization.
Kobiler D; Gozes Y; Rosenberg H; Marcus D; Reuveny S; Altboum Z
Infect Immun; 2002 Feb; 70(2):544-60. PubMed ID: 11796581
[TBL] [Abstract][Full Text] [Related]
5. Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine.
Schneerson R; Kubler-Kielb J; Liu TY; Dai ZD; Leppla SH; Yergey A; Backlund P; Shiloach J; Majadly F; Robbins JB
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8945-50. PubMed ID: 12857944
[TBL] [Abstract][Full Text] [Related]
6. Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis.
Singh Y; Ivins BE; Leppla SH
Infect Immun; 1998 Jul; 66(7):3447-8. PubMed ID: 9632621
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge.
Mohamadzadeh M; Duong T; Sandwick SJ; Hoover T; Klaenhammer TR
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4331-6. PubMed ID: 19246373
[TBL] [Abstract][Full Text] [Related]
8. A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.
Manish M; Rahi A; Kaur M; Bhatnagar R; Singh S
PLoS One; 2013; 8(4):e61885. PubMed ID: 23637922
[TBL] [Abstract][Full Text] [Related]
9. Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge.
Koya V; Moayeri M; Leppla SH; Daniell H
Infect Immun; 2005 Dec; 73(12):8266-74. PubMed ID: 16299323
[TBL] [Abstract][Full Text] [Related]
10. Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4.
McConnell MJ; Hanna PC; Imperiale MJ
Infect Immun; 2006 Feb; 74(2):1009-15. PubMed ID: 16428747
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults.
Brown BK; Cox J; Gillis A; VanCott TC; Marovich M; Milazzo M; Antonille TS; Wieczorek L; McKee KT; Metcalfe K; Mallory RM; Birx D; Polonis VR; Robb ML
PLoS One; 2010 Nov; 5(11):e13849. PubMed ID: 21079762
[TBL] [Abstract][Full Text] [Related]
12. Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugates.
Kubler-Kielb J; Liu TY; Mocca C; Majadly F; Robbins JB; Schneerson R
Infect Immun; 2006 Aug; 74(8):4744-9. PubMed ID: 16861662
[TBL] [Abstract][Full Text] [Related]
13. Anthrax lethal factor inhibition.
Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
[TBL] [Abstract][Full Text] [Related]
14. The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen.
Wang TT; Lucas AH
Infect Immun; 2004 Sep; 72(9):5460-3. PubMed ID: 15322045
[TBL] [Abstract][Full Text] [Related]
15. Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.
Gat O; Grosfeld H; Ariel N; Inbar I; Zaide G; Broder Y; Zvi A; Chitlaru T; Altboum Z; Stein D; Cohen S; Shafferman A
Infect Immun; 2006 Jul; 74(7):3987-4001. PubMed ID: 16790772
[TBL] [Abstract][Full Text] [Related]
16. BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis.
Kern J; Schneewind O
Mol Microbiol; 2010 Jan; 75(2):324-32. PubMed ID: 19906175
[TBL] [Abstract][Full Text] [Related]
17. Secondary cell wall polysaccharides of Bacillus anthracis are antigens that contain specific epitopes which cross-react with three pathogenic Bacillus cereus strains that caused severe disease, and other epitopes common to all the Bacillus cereus strains tested.
Leoff C; Saile E; Rauvolfova J; Quinn CP; Hoffmaster AR; Zhong W; Mehta AS; Boons GJ; Carlson RW; Kannenberg EL
Glycobiology; 2009 Jun; 19(6):665-73. PubMed ID: 19270075
[TBL] [Abstract][Full Text] [Related]
18. Quantifying in vitro B. anthracis growth and PA production and decay: a mathematical modelling approach.
Williams B; Paterson J; Rawsthorne-Manning HJ; Jeffrey PA; Gillard JJ; Lythe G; Laws TR; López-García M
NPJ Syst Biol Appl; 2024 Mar; 10(1):33. PubMed ID: 38553532
[TBL] [Abstract][Full Text] [Related]
19. LETHAL TOXIN NEUTRALIZING ANTIBODY RESPONSE INDUCED FOLLOWING ORAL VACCINATION WITH A MICROENCAPSULATED
Benn JS; Nunez CM; Blue-McLendon A; Chaki SP; Ficht TA; Rice-Ficht AC; Cook WE
J Zoo Wildl Med; 2024 Mar; 55(1):212-218. PubMed ID: 38453505
[TBL] [Abstract][Full Text] [Related]
20. Single Low-Dose Nanovaccine for Long-Term Protection against Anthrax Toxins.
Holay M; Krishnan N; Zhou J; Duan Y; Guo Z; Gao W; Fang RH; Zhang L
Nano Lett; 2022 Dec; 22(23):9672-9678. PubMed ID: 36448694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
